POGGESI, ITALO
 Distribuzione geografica
Continente #
EU - Europa 967
NA - Nord America 880
AS - Asia 592
SA - Sud America 64
Continente sconosciuto - Info sul continente non disponibili 35
AF - Africa 32
OC - Oceania 8
Totale 2.578
Nazione #
US - Stati Uniti d'America 853
NL - Olanda 476
CN - Cina 281
IE - Irlanda 142
SG - Singapore 142
RU - Federazione Russa 79
HK - Hong Kong 59
IT - Italia 52
DE - Germania 50
BR - Brasile 45
VN - Vietnam 43
FI - Finlandia 41
UA - Ucraina 35
ZA - Sudafrica 23
GB - Regno Unito 21
FR - Francia 19
SE - Svezia 15
CA - Canada 14
IN - India 14
PL - Polonia 12
MX - Messico 9
AR - Argentina 8
BD - Bangladesh 8
AU - Australia 7
IQ - Iraq 5
KR - Corea 5
LT - Lituania 5
CO - Colombia 4
ES - Italia 4
JP - Giappone 4
TR - Turchia 4
AT - Austria 3
BE - Belgio 3
EC - Ecuador 3
ET - Etiopia 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
ID - Indonesia 1
JM - Giamaica 1
LK - Sri Lanka 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
SN - Senegal 1
TW - Taiwan 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 2.544
Città #
Dublin 142
Chandler 100
Singapore 99
San Jose 95
Beijing 67
Hong Kong 58
Ashburn 57
Dallas 49
Jacksonville 49
Nanjing 45
Boardman 32
Los Angeles 30
Helsinki 22
Council Bluffs 21
Johannesburg 21
Princeton 20
Wilmington 19
Hebei 17
Lawrence 17
Nanchang 17
Shanghai 17
Medford 16
Milan 16
Dearborn 15
Jiaxing 15
Lauterbourg 15
Changsha 14
Ho Chi Minh City 14
Shenyang 13
Ann Arbor 12
Moscow 12
Buffalo 10
Hanoi 9
Munich 9
New York 9
Pavia 8
Santa Clara 8
Tianjin 8
Warsaw 8
Chicago 7
Hangzhou 7
Orem 7
Redondo Beach 7
Seattle 7
Toronto 7
São Paulo 6
Atlanta 5
Houston 5
Irvington 5
Mexico City 5
San Francisco 5
Cagliari 4
Frankfurt am Main 4
Piscataway 4
Tokyo 4
Woodbridge 4
Bangkok 3
Belo Horizonte 3
Brooklyn 3
Brussels 3
Hải Dương 3
Krakow 3
Montreal 3
Mumbai 3
Nuremberg 3
Saint Petersburg 3
Sydney 3
The Dalles 3
Zhengzhou 3
Addis Ababa 2
Augusta 2
Bishkek 2
Boston 2
Brasília 2
Bratislava 2
Changchun 2
Charlotte 2
Chennai 2
Coimbra 2
Concord 2
Da Nang 2
Denver 2
Dhaka 2
Düsseldorf 2
Garching 2
Hackney 2
Kuching 2
Kuwait City 2
London 2
Manhumirim 2
Nairobi 2
New Delhi 2
Norwalk 2
Nova Iguaçu 2
Oklahoma City 2
Patchogue 2
Perth 2
Pittsburgh 2
Poplar 2
Quito 2
Totale 1.399
Nome #
Steady-state equivalence of drug- and biomarker driven models in tumor growth experiments 594
Tumor-growth inhibition in preclinical animal studies: steady-state analysis of biomarker-driven models 184
Biomarker-driven models of tumor growth inhibition in preclinical animal studies 158
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression 133
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies 126
Use of Physiology-Based Elements to Predict the Pharmacokineticsof New Drugs 119
Tumor growth modelling for drug development 118
Method to evaluate the systemic exposure in toxicological and pharmacological studies 109
Current mathematical models for cancer drug discovery 109
Predictive assessments of pharmacokinetic alterations in subjects with renal disease 105
Biomarker- versus drug-driven tumor growth inhibition models: an equivalence analysis 101
Mathematical modeling of efficacy and safety for anticancer drugs clinical development 99
Pharmacokinetic-Pharmacodynamic Modeling in Drug Development with Special Reference to Oncology 96
Biomarker- versus drug-driven tumor growth inhibition models: an equivalence analysis 92
A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension 92
A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib 87
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial 86
Modeling approaches for reducing safety-related attrition in drug discovery and development: a review on myelotoxicity, immunotoxicity, cardiovascular toxicity, and liver toxicity 86
Prediction of the Effect of Renal Impairment on the Pharmacokinetics of New Drugs 84
Totale 2.578
Categoria #
all - tutte 9.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022560 0 0 4 0 1 2 0 18 1 0 16 518
2022/2023340 40 27 10 12 25 25 1 19 161 3 7 10
2023/2024129 32 20 0 12 8 17 9 15 2 4 6 4
2024/2025311 8 24 6 4 23 4 7 30 97 7 39 62
2025/2026799 61 45 74 85 121 34 130 31 86 80 15 37
2026/202751 14 34 3 0 0 0 0 0 0 0 0 0
Totale 2.578